Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function Mutation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical immunology 2021-05, Vol.41 (4), p.807-810
Hauptverfasser:	Sarfati, Eytan, Hadjadj, Jérome, Fusaro, Mathieu, Klifa, Roman, Grimaud, Marion, Berteloot, Laureline, Hadchouel, Alice, Godot, Cécile, Stolzenberg, Marie-Claude, Frémond, Marie-Louise, Pressiat, Claire, Molina, Thierry, Fischer, Alain, Picard, Capucine, Renolleau, Sylvain, Rieux-Laucat, Frederic, Blanche, Stephane, Neven, Benedicte
Format:	Artikel
Sprache:	eng
Schlagworte:	Alleles Biomedical and Life Sciences Biomedicine Disease Management Gain of Function Mutation Genetic Association Studies Genetic Predisposition to Disease Genotype Germ-Line Mutation Humans Immune System Diseases - diagnosis Immune System Diseases - drug therapy Immune System Diseases - etiology Immunology Infectious Diseases Internal Medicine Janus Kinase Inhibitors - administration & dosage Janus Kinase Inhibitors - adverse effects Janus Kinase Inhibitors - therapeutic use Letter to Editor Medical Microbiology Molecular Targeted Therapy - methods Phenotype Stat3 protein STAT3 Transcription Factor - genetics Tomography, X-Ray Computed Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!